Caisse DE Depot ET Placement DU Quebec Has $199.44 Million Position in Colgate-Palmolive (NYSE:CL)

Caisse DE Depot ET Placement DU Quebec cut its holdings in Colgate-Palmolive (NYSE:CL) by 28.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 1,921,168 shares of the company’s stock after selling 773,948 shares during the quarter. Caisse DE Depot ET Placement DU Quebec owned approximately 0.24% of Colgate-Palmolive worth $199,436,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Main Street Research LLC increased its stake in shares of Colgate-Palmolive by 1.5% in the 2nd quarter. Main Street Research LLC now owns 6,939 shares of the company’s stock valued at $673,000 after buying an additional 100 shares during the period. Advisor OS LLC lifted its position in Colgate-Palmolive by 4.5% during the 2nd quarter. Advisor OS LLC now owns 2,348 shares of the company’s stock valued at $228,000 after purchasing an additional 101 shares during the period. BLB&B Advisors LLC boosted its stake in shares of Colgate-Palmolive by 2.5% in the 2nd quarter. BLB&B Advisors LLC now owns 4,337 shares of the company’s stock valued at $421,000 after purchasing an additional 104 shares during the last quarter. D Orazio & Associates Inc. raised its stake in shares of Colgate-Palmolive by 3.9% during the third quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock worth $297,000 after buying an additional 108 shares during the last quarter. Finally, ZWJ Investment Counsel Inc. lifted its holdings in Colgate-Palmolive by 3.1% in the second quarter. ZWJ Investment Counsel Inc. now owns 3,591 shares of the company’s stock valued at $349,000 after buying an additional 109 shares during the period. 80.41% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have commented on the stock. JPMorgan Chase & Co. upped their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Stifel Nicolaus lowered shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and cut their target price for the stock from $105.00 to $101.00 in a report on Monday, October 28th. UBS Group raised their price objective on Colgate-Palmolive from $119.00 to $122.00 and gave the stock a “buy” rating in a research note on Wednesday, September 4th. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a report on Monday, October 28th. Finally, StockNews.com raised shares of Colgate-Palmolive from a “hold” rating to a “buy” rating in a research report on Monday, November 25th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $105.11.

Colgate-Palmolive Trading Down 0.2 %

CL stock opened at $96.60 on Friday. Colgate-Palmolive has a 52 week low of $75.50 and a 52 week high of $109.30. The company has a market capitalization of $78.92 billion, a PE ratio of 27.68, a price-to-earnings-growth ratio of 3.45 and a beta of 0.42. The company’s 50-day simple moving average is $97.38 and its 200 day simple moving average is $98.58. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 2.07%. The ex-dividend date of this dividend was Friday, October 18th. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the transaction, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. The trade was a 55.29 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.34% of the company’s stock.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.